Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies

Hubatsch Doug; Realini Tony

首页> 外文期刊>Investigative ophthalmology & visual science >Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies

【24h】

Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies

机译：固定剂量组合的疗效和安全性1％/溴醌0.2％作为升高的眼压患者前列腺素类似物的辅助治疗：两种多中心的汇总分析结果的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共2页
作者
Hubatsch Doug; Realini Tony;
展开▼
作者单位

Novartis Pharmaceut Ft Worth TX USA;

West Virginia Univ Dept Ophthalmol Morgantown WV USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献

1. Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies [J] . Hubatsch Doug, Realini Tony Investigative ophthalmology & visual science . 2017,第8期

机译：固定剂量组合的疗效和安全性1％/溴醌0.2％作为升高的眼压患者前列腺素类似物的辅助治疗：两种多中心的汇总分析结果的结果
2. Comparison of the change in intraocular pressure with a fixed-dose combination of brinzolamide 1% and brimonidine 0.2% vs brinzolamide or brimonidine alone in patients with open-angle glaucoma or ocular hypertension: A post hoc, pooled, phase 3 analysis [J] . Meng Xiangyi, Sall Kenneth N., Wirta David, Investigative ophthalmology & visual science . 2018,第9期

机译：用溴齐胺的固定剂量组合的眼压变化与溴尼甘蓝醇的固定剂量组合0.2％与溴齐甲酰胺或双模参单独的患者单独的肺炎或眼镜高血压患者：HOC，合并，相3分析
3. Comparison of the change in intraocular pressure with a fixed-dose combination of brinzolamide 1% and brimonidine 0.2% vs brinzolamide or brimonidine alone in patients with open-angle glaucoma or ocular hypertension: A post hoc, pooled, phase 3 analysis [J] . Meng Xiangyi, Sall Kenneth N., Wirta David, Investigative ophthalmology & visual science . 2018,第9期

机译：用溴齐胺的固定剂量组合的眼压变化与溴尼甘蓝醇的固定剂量组合0.2％与溴齐甲酰胺或双模参单独的患者单独的肺炎或眼镜高血压患者：HOC，合并，相3分析
4. Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension [O] . Ningli Wang, Da-Wen Lu, Yingzi Pan, 2020

机译：Brinzolamide / Brimonidine固定剂量组合与同时使用Brinzolamide和Brimonidine来治疗开角型青光眼或高眼压的眼内降压功效和安全性比较
5. A Randomized Trial of Fixed-Dose Combination Brinzolamide 1/Brimonidine 0.2 as Adjunctive Therapy to Travoprost 0.004 [O] . Feldman Robert M., Katz Gregory, McMenemy Matthew, 2016

机译：固定剂量联合用1％溴苯甲酰胺/ 0.2％溴莫尼定作为Travoprost辅助治疗的随机试验0.004％

Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies

著录项

相似文献

相关主题

期刊订阅